# Thymogen (Glu-Trp)

Source: https://aminodesk.com/library/thymogen
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

Thymogen is a peptide of just two amino acids, glutamic acid and tryptophan. It was identified in the search for the active part of the thymus extract Thymalin and has been a registered immune drug in Russia since 1990. It is not approved in the US.

- **Legal lane:** registered in Russia. Not FDA-approved.
- **Evidence grade:** C. Decades of clinical use in one country; little that meets modern trial standards.
- **Form:** injection and nasal spray in Russia
- **What it is:** the dipeptide Glu-Trp

## What it is

Researchers looking for the active components of [Thymalin](https://aminodesk.com/library/thymalin) arrived at the dipeptide Glu-Trp, which was registered as the drug Thymogen in 1990. A review of Russian peptide medicines lists it among the country's original registered peptide drugs, as an immune stimulant.

## What the evidence shows

The clinical record is Russian and comes largely from the group that developed it. Their own reviews describe use in infections and in older patients.

A Russian drug handbook cited by St. Petersburg journalists lists Thymogen, like Thymalin, as having no evidence-based effectiveness. We found no large blinded trial in the sources we reviewed.

## Legal status

- A registered drug in Russia.
- Not approved by the FDA.
- Not eligible for pharmacy compounding in the US, according to the research summary we read, and not one of the six peptides in the October 2026 policy.

## Reported dosing

**We do not publish a protocol for this compound.**

The Russian product has its own label, which we have not been able to check directly. Figures on seller sites are not a source.

## Safety

- A published chemistry review describes it as free of allergic and other side reactions. That is the developers' literature, not an independent safety review.
- Products sold abroad under this name are not the registered Russian product and have no verified contents.

## Common questions

### What is Thymogen?

A two-amino-acid peptide, Glu-Trp, registered as an immune drug in Russia.

### Is Thymogen FDA-approved?

No.

### How is Thymogen related to Thymalin?

It was identified as an active component of the Thymalin thymus extract and then made synthetically.

## Sources

- [Molecules, 2021: history of Thymalin (1982) and Thymogen (1990) registration](https://mdpi.com/1420-3049/26/21/6550)
- [Review of peptide drugs registered in the Russian Federation](https://pmc.ncbi.nlm.nih.gov/articles/PMC9030433)
- [Paper (St. Petersburg), 2024: Khavinson's drugs and their critics in evidence-based medicine](https://papernews.online/en/he-promised-to-extend-the-lives/)
- [Khavinson, Kuznik and Ryzhak, 2014: the developers' own review of clinical use](https://khavinson.info/assets/files/2014-Khavinson_Kuznik.pdf)
- [The Peptide Column: bioregulator research summary and legal status](https://the-peptide-column.pages.dev/bioregulators)

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
